Literature DB >> 423057

Hematologic consequences of chloramphenicol therapy.

F A Oski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 423057     DOI： 10.1016/s0022-3476(79)80639-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  6 in total

Review 1.  Drug-induced myelosuppression : diagnosis and management.

Authors:  Peter J Carey
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Assessment of exposure to chloramphenicol and azathioprine among workers in a South African pharmaceutical plant.

Authors:  M Jeebhay; S Mbuli; R Uebel
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

Review 3.  Chloramphenicol in the 1980s.

Authors:  I Shalit; M I Marks
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

4.  Rapid estimation of chloramphenicol clearance in infants and children.

Authors:  J R Koup; C M Sack; A L Smith; N N Neely; M Gibaldi
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.

Authors:  P J Ambrose
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

6.  Chloramphenicol toxicity revisited: a 12-year-old patient with a brain abscess.

Authors:  Donald B Wiest; Joel B Cochran; Fred W Tecklenburg
Journal:  J Pediatr Pharmacol Ther       Date:  2012-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.